NinePoint Medical company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ninepointmedical.com

Stage

Dead | Dead

Total Raised

$97.98M

About NinePoint Medical

NinePoint Medical improves patient care through the development of medical devices that enable high-resolution in-vivo imaging. Using advanced optical technologies, NinePoint Medical empowers treating physicians and pathologists to image cross-sectionally to visualize features at and below the mucosal surface, over very large areas. The company delivers imaging information to support clinical decision-making relative to biopsy placement and treatment planning.

NinePoint Medical Headquarter Location

12 Oak Park Drive

Bedford, Massachusetts, 01730,

United States

617-250-7190

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NinePoint Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NinePoint Medical is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,368 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

H

Health IT

7,900 items

NinePoint Medical Patents

NinePoint Medical has filed 22 patents.

The 3 most popular patent topics include:

  • Interferometers
  • Interferometry
  • Laser medicine
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/2/2019

11/16/2021

Telecommunication theory, Interferometers, Interferometry, Laser medicine, Frequency domain analysis

Grant

Application Date

12/2/2019

Grant Date

11/16/2021

Title

Related Topics

Telecommunication theory, Interferometers, Interferometry, Laser medicine, Frequency domain analysis

Status

Grant

Latest NinePoint Medical News

NinePoint Medical, Inc. Enters Into A Strategic Partnership and Worldwide Distribution with Merit Medical Systems, Inc.

May 25, 2021

May 01, 2018 08:19 AM Eastern Daylight Time BEDFORD, Mass.--( BUSINESS WIRE )-- NinePoint Medical, Inc , a transformative medical device company pioneering the use of Optical Coherence Tomography (OCT) for gastrointestinal applications, today announced a long-term strategic partnership with Merit Medical Systems, Inc. (NASDAQ: MMSI ). This partnership includes a strategic investment and a worldwide distribution agreement with Merit Medical’s endoscopic division, Merit Medical Endotek® (Endotek), for NinePoint Medical’s NvisionVLE® Imaging System with Real-time Targeting™. This partnership combines the world-class Gastrointestinal (GI) and Pulmonary medical devices from Endotek with the ground-breaking Advanced OCT platform from NinePoint Medical. This OCT platform has, in a short period of time, become a primary imaging device used by many of the leading hospitals in the U.S. to aid in the early detection of esophageal cancer. “NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” commented Christopher R. von Jako, Ph.D., President and Chief Executive Officer of NinePoint Medical. “Merit Medical Endotek is the ideal partner as they have the reputation, clinical experience, and complementary product portfolio to grow this business.” “We are very excited to form this partnership in order to provide NinePoint Medical’s highly innovative OCT imaging system to our customers and other clinicians around the world,” said Merit Medical System’s Chairman and Chief Executive Officer Fred P. Lampropoulos. “Endotek is a market leader in GI solutions, and we share NinePoint Medical’s vision of improving early cancer detection and thereby improving patient outcomes while reducing healthcare costs.” The NvisionVLE Imaging System provides a unique and clinically valuable new perspective on esophageal disease - the ability to image within the wall of the esophagus. By providing a high-resolution, real-time scan of the esophagus using Optical Coherence Tomography (OCT) – a technology similar to ultrasound but using infrared light rather than sound waves - the system enables physicians to view structures not evident with conventional imaging, and potentially identify disease that would have otherwise been missed. With the recent addition of a Real-time TargetingTM feature, physicians can not only locate, but now mark areas of interest. This marking feature, in combination with an improved workflow, enables more accurate targeting, potentially leading to improved diagnosis and more effective therapeutic decisions for patients. The NvisionVLE® Imaging System has been cleared by the FDA and is commercially available in the U.S. It is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and may be used to mark areas of tissue. The safety and efficacy of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specific disease has not been evaluated. NinePoint Medical is a privately-held medical device company that designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, and ENT, for the evaluation of human tissue microstructure. Using proprietary imaging and software technology, the Company is committed to enabling quicker diagnosis of disease and more effective treatments, while reducing the overall cost of healthcare. NinePoint Medical is located in suburban Boston, Massachusetts. For more information, please visit www.ninepointmedical.com . Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Yishun, Singapore.

  • Where is NinePoint Medical's headquarters?

    NinePoint Medical's headquarters is located at 12 Oak Park Drive, Bedford.

  • What is NinePoint Medical's latest funding round?

    NinePoint Medical's latest funding round is Dead.

  • How much did NinePoint Medical raise?

    NinePoint Medical raised a total of $97.98M.

  • Who are NinePoint Medical's competitors?

    Competitors of NinePoint Medical include Itamar Medical, Simbionix, BioProtect, GENICON, Sphere Medical and 13 more.

You May Also Like

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

K
Kolkata Perfint

Perfint is a medica device company. The company's first product called - PIGA, a Tool Positioner for performing facilitating Image Guided Minimally Invasive procedures in CT environment. PIGA aims to allow radiologists to perform procedures like FNA, Biopsy, RFA in Thorax and Abdomen region more accurately.

S
Surgi-Vision

Surgi-Vision, Inc. is engaged in the development of sighting and visualization systems that allow a magnified stereoscopic vision of the surgical field and visualization of other intra-operative digital data during minimally invasive procedures. Surgi-Vision manufacturers specialized MRI coils that are used to take images from inside the body. Surgi-Vision received 510K clearance from the Food & Drug Administration (FDA) for clinical use of a new coil to image the esophagus and aorta.

M
Mst (Medical Smart Tools)

MST - Medical Smart Tools was founded in 2004 with the mission to develop image guided surgery technology solutions. The Company aims to improve laparoscopic and other minimally invasive surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes. MST is working within NGT, a private technological incubator in Nazareth, Israel. MST presents the market with a smart disposable Robotic Arm camera holder for laparoscopy, based on advanced image technology. The system is comprised of a computer-controlled mechanism for mechanical camera motivation, intuitive interface between the surgeon and the mechanical system. The company's R&D efforts are spearheaded by a core group of engineers with expertise in image processing, dynamics of mechanisms, multi-link systems and biomechanics. The Company is backed by strong and experienced management and professional medical advisors.

BioProtect Logo
BioProtect

BioProtect has developed a minimally invasive, biodegradable, biological balloon implant which reduces rectal toxicity in prostate cancer radiation therapy.

A
Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial (www.axialbiotech.com) is located in Salt Lake City, Utah.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.